Zhengye Biotechnology Holding Limited ZYBT
1.52 USD +0.02 (+1.33%)
Regular-session close
1.49 -0.03 -1.97%
After hours · Nov 19, 4:00 PM ET
1.44 Day range 1.52
0.616 52-week range 8.01
- YTD
- +32.17%
- 1 year
- -29.30%
News
benzinga.com Zhengye Biotechnology H1 EPS $(0.06), Same YoY, Sales $7.509M Down From $8.701M YoY Zhengye Biotechnology (NASDAQ:ZYBT) reported quarterly losses of $(0.06) per share. This is unchanged from the same period last year. The company reported $7.509 million in sales this quarter. This…
prnewswire.com Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026 JILIN, China, Nov. 12, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement Jilin, China, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Jilin, China, June 04, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,…
prnewswire.com Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results JILIN, China, April 28, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research,…
defenseworld.net Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Declines By 36.7% Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 13th, there was short interest…
globenewswire.com Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders Jilin, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research,…
prnewswire.com Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results JILIN, China , July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,…
seekingalpha.com U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline Three very small Asian issuers and one blank check company listed in the US this past week, though the biggest headlines came from a sizable launch and notable new filings. Energy equipment and…
globenewswire.com Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research,…
globenewswire.com Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development,…
seekingalpha.com Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO Zhengye Biotechnology Holding Limited has filed for a $20 million IPO to raise capital for its acquisition program and new development capabilities. The company's revenue has declined, but it still…
